Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers.
Clinical trials form the evidence base for medical decision making and may provide patients with life-threatening conditions their best chance to find an effective treatment. A growing number of states and the federal government are mandating coverage of the routine costs of cancer clinical trials, although the extent of coverage varies. Individual health plans are following suit on behalf of their beneficiaries. Trials conducted at the National Cancer Institute (NCI) are an attractive resource for payers, because NCI provides medical services at no charge, enables patient access to promising care, emphasizes continuity with patients' regular physicians, and makes the referral and enrollment process easy and efficient through its Clinical Studies Support Center's toll-free information line 1-888-NCI-1937.
Pearson
Deborah
D
Office of Outreach and Patient Recruitment Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
D002986:Clinical Trials as Topic / Q000191:economics*; D003266:Continuity of Patient Care; D003299:Cooperative Behavior; D017048:Health Care Costs; D006297:Health Services Accessibility; D006801:Humans; D019458:Insurance Coverage / Q000331:legislation & jurisprudence*; D007348:Insurance, Health; D007349:Insurance, Health, Reimbursement; D008329:Managed Care Programs; D008484:Medicaid; D006278:Medicare; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D012017:Referral and Consultation; D012109:Research Support as Topic / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States